Arteriosclerosis, Thrombosis, and Vascular Biology. 2005;25:1
doi: 10.1161/01.ATV.0000153738.88475.f7
doi: 10.1161/01.ATV.0000153738.88475.f7
© 2005 American Heart Association, Inc.
Announcement |
New Investigator Awards
Beginning in 2005, three new investigators will be honored each year for their outstanding papers in Arteriosclerosis, Thrombosis, and Vascular Biology. The first authors of one original paper each year in each section of the journal (Vascular Biology, Atherosclerosis and Lipoproteins, and Thrombosis) will be honored. Goals of the awards are to recognize outstanding work by new investigators, and to encourage investigators to send their best work to ATVB. Each recipient of the award will receive a plaque and a check for $2500, funded by Lippincott, Williams, & Wilkins.Eligibility
The first or last author must be an Assistant Professor (or equivalent) or a more junior rank at the time of submission of the manuscript. Authors should indicate, at the time of submission of the manuscript, that they would like to be considered for the award. For papers that have already been submitted or accepted, authors should indicate by email to an ATVB editorial office that they would like to be considered. Candidates should also submit a two-page biographical sketch, including a list of key full-length papers.
Criteria and Selection
Awards will be based on the quality of the paper that is published and, to a lesser extent, other achievements of the author, as summarized in the biographical sketch. To be considered, a paper must be published in 2005. Awards are also planned for subsequent years.
Selection committees for each of the awards will include Editors and Associate Editors from the Asian, European. and U.S. offices. Recipients of Awards will be recognized in the Journal.
If you have questions about eligibility, criteria, or other aspects of the awards, please contact an ATVB editorial office.
Donald D. Heistad, MD
For the Editors
This article has been cited by other articles:
 |
|
 |
|
  C Lopez-Pedrera, N Barbarroja, M. Aguirre, L. Torres, F Velasco, and M. Cuadrado Genomics and proteomics: a new approach for assessing thrombotic risk in autoimmune diseases Lupus, October 1, 2008; 17(10): 905 - 916. [Abstract] [PDF]
|
|
|
|
 |
|
 T. J.L. Van De Parre, W. Martinet, S. Verheye, M. M. Kockx, G. Van Langenhove, A. G. Herman, and G. R.Y. De Meyer Mitochondrial uncoupling protein 2 mediates temperature heterogeneity in atherosclerotic plaques Cardiovasc Res, January 15, 2008; 77(2): 425 - 431. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. S Kramer, L. Matush, I. Vanilovich, R. W Platt, N. Bogdanovich, Z. Sevkovskaya, I. Dzikovich, G. Shishko, J.-P. Collet, R. M Martin, et al. Effects of prolonged and exclusive breastfeeding on child height, weight, adiposity, and blood pressure at age 6.5 y: evidence from a large randomized trial Am. J. Clinical Nutrition, December 1, 2007; 86(6): 1717 - 1721. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Martino, P. Pignatelli, E. Martino, F. Morrone, R. Carnevale, S. Di Santo, B. Buchetti, L. Loffredo, and F. Violi Early Increase of Oxidative Stress and Soluble CD40L in Children With Hypercholesterolemia J. Am. Coll. Cardiol., May 15, 2007; 49(19): 1974 - 1981. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Dong, S. Fujii, S. Imagawa, S. Matsumoto, M. Matsushita, S. Todo, H. Tsutsui, and B. E. Sobel IL-1 and IL-6 induce hepatocyte plasminogen activator inhibitor-1 expression through independent signaling pathways converging on C/EBP{delta} Am J Physiol Cell Physiol, January 1, 2007; 292(1): C209 - C215. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. C. M. C. Koeijvoets, E. F. C. van Rossum, G. M. Dallinga-Thie, E. W. Steyerberg, J. C. Defesche, J. J. P. Kastelein, S. W. J. Lamberts, and E. J. G. Sijbrands A Functional Polymorphism in the Glucocorticoid Receptor Gene and Its Relation to Cardiovascular Disease Risk in Familial Hypercholesterolemia J. Clin. Endocrinol. Metab., October 1, 2006; 91(10): 4131 - 4136. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. L. Crandall, E. M. Quinet, S. El Ayachi, A. L. Hreha, C. E. Leik, D. A. Savio, I. Juhan-Vague, and M.-C. Alessi Modulation of Adipose Tissue Development by Pharmacological Inhibition of PAI-1 Arterioscler Thromb Vasc Biol, October 1, 2006; 26(10): 2209 - 2215. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-F. Lee, Q. Zeng, H. Ozaki, L. Wang, A. R. Hand, T. Hla, E. Wang, and M.-J. Lee Dual Roles of Tight Junction-associated Protein, Zonula Occludens-1, in Sphingosine 1-Phosphate-mediated Endothelial Chemotaxis and Barrier Integrity J. Biol. Chem., September 29, 2006; 281(39): 29190 - 29200. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Maffia, G. Grassia, P. Di Meglio, R. Carnuccio, L. Berrino, P. Garside, A. Ianaro, and A. Ialenti Neutralization of Interleukin-18 Inhibits Neointimal Formation in a Rat Model of Vascular Injury Circulation, August 1, 2006; 114(5): 430 - 437. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-H. Yoon, J. Hur, I.-Y. Oh, K.-W. Park, T.-Y. Kim, J.-H. Shin, J.-H. Kim, C.-S. Lee, J.-K. Chung, Y.-B. Park, et al. Intercellular Adhesion Molecule-1 Is Upregulated in Ischemic Muscle, Which Mediates Trafficking of Endothelial Progenitor Cells Arterioscler Thromb Vasc Biol, May 1, 2006; 26(5): 1066 - 1072. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Suzuki, M. Iwai, M. Mogi, A. Oshita, T. Yoshii, J. Higaki, and M. Horiuchi Eplerenone With Valsartan Effectively Reduces Atherosclerotic Lesion by Attenuation of Oxidative Stress and Inflammation Arterioscler Thromb Vasc Biol, April 1, 2006; 26(4): 917 - 921. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. W. Clark, R. B. Ruggeri, D. Cunningham, and M. J. Bamberger Description of the torcetrapib series of cholesteryl ester transfer protein inhibitors, including mechanism of action J. Lipid Res., March 1, 2006; 47(3): 537 - 552. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. H. Wild, C. D. Byrne, F. B. Smith, A. J. Lee, and F. G. R. Fowkes Low ankle-brachial pressure index predicts increased risk of cardiovascular disease independent of the metabolic syndrome and conventional cardiovascular risk factors in the edinburgh artery study. Diabetes Care, March 1, 2006; 29(3): 637 - 642. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. K. Naka, A. C. Tweddel, S. N. Doshi, J. Goodfellow, and A. H. Henderson Flow-mediated changes in pulse wave velocity: a new clinical measure of endothelial function Eur. Heart J., February 1, 2006; 27(3): 302 - 309. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Tomiyama, H. Hashimoto, Y. Hirayama, M. Yambe, J. Yamada, Y. Koji, K. Shiina, Y. Yamamoto, and A. Yamashina Synergistic Acceleration of Arterial Stiffening in the Presence of Raised Blood Pressure and Raised Plasma Glucose Hypertension, February 1, 2006; 47(2): 180 - 188. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. De Palma, E. Meacci, C. Perrotta, P. Bruni, and E. Clementi Endothelial Nitric Oxide Synthase Activation by Tumor Necrosis Factor {alpha} Through Neutral Sphingomyelinase 2, Sphingosine Kinase 1, and Sphingosine 1 Phosphate Receptors: A Novel Pathway Relevant to the Pathophysiology of Endothelium Arterioscler Thromb Vasc Biol, January 1, 2006; 26(1): 99 - 105. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. D. Loomis, J. C. Sullivan, D. A. Osmond, D. M. Pollock, and J. S. Pollock Endothelin Mediates Superoxide Production and Vasoconstriction through Activation of NADPH Oxidase and Uncoupled Nitric-Oxide Synthase in the Rat Aorta J. Pharmacol. Exp. Ther., December 1, 2005; 315(3): 1058 - 1064. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Hill, M. A. Syed, A. E. Arai, T. M. Powell, J. D. Paul, G. Zalos, E. J. Read, H. M. Khuu, S. F. Leitman, M. Horne, et al. Outcomes and Risks of Granulocyte Colony-Stimulating Factor in Patients With Coronary Artery Disease J. Am. Coll. Cardiol., November 1, 2005; 46(9): 1643 - 1648. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Li, E. J. Barrett, H. Wang, W. Chai, and Z. Liu Insulin at Physiological Concentrations Selectively Activates Insulin But Not Insulin-Like Growth Factor I (IGF-I) or Insulin/IGF-I Hybrid Receptors in Endothelial Cells Endocrinology, November 1, 2005; 146(11): 4690 - 4696. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Torzewski C-Reactive Protein and Atherogenesis: New Insights from Established Animal Models Am. J. Pathol., October 1, 2005; 167(4): 923 - 925. [Full Text] [PDF]
|
|
|
|
|
|
V. Fuster, P. R. Moreno, Z. A. Fayad, R. Corti, and J. J. Badimon Atherothrombosis and High-Risk Plaque: Part I: Evolving Concepts J. Am. Coll. Cardiol., September 20, 2005; 46(6): 937 - 954. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-H. Yoon, J. Hur, K.-W. Park, J.-H. Kim, C.-S. Lee, I.-Y. Oh, T.-Y. Kim, H.-J. Cho, H.-J. Kang, I.-H. Chae, et al. Synergistic Neovascularization by Mixed Transplantation of Early Endothelial Progenitor Cells and Late Outgrowth Endothelial Cells: The Role of Angiogenic Cytokines and Matrix Metalloproteinases Circulation, September 13, 2005; 112(11): 1618 - 1627. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Challier, S. Jacqueminet, O. Benabdesselam, A. Grimaldi, and J.-L. Beaudeux Increased Serum Concentrations of Soluble Receptor for Advanced Glycation Endproducts in Patients with Type 1 Diabetes Clin. Chem., September 1, 2005; 51(9): 1749 - 1750. [Full Text] [PDF]
|
|
|
|
|
|
N. Rotllan, V. Ribas, L. Calpe-Berdiel, J. M. Martin-Campos, F. Blanco-Vaca, and J. C. Escola-Gil Overexpression of Human Apolipoprotein A-II in Transgenic Mice Does Not Impair Macrophage-Specific Reverse Cholesterol Transport In Vivo Arterioscler Thromb Vasc Biol, September 1, 2005; 25(9): e128 - e132. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Hausleiter, A. Kastrati, R. Wessely, A. Dibra, J. Mehilli, T. Schratzenstaller, I. Graf, M. Renke-Gluszko, B. Behnisch, J. Dirschinger, et al. Prevention of restenosis by a novel drug-eluting stent system with a dose-adjustable, polymer-free, on-site stent coating Eur. Heart J., August 1, 2005; 26(15): 1475 - 1481. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. J. Dzau, M. Gnecchi, A. S. Pachori, F. Morello, and L. G. Melo Therapeutic Potential of Endothelial Progenitor Cells in Cardiovascular Diseases Hypertension, July 1, 2005; 46(1): 7 - 18. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. W. Raines and N. Ferri Thematic Review Series: The Immune System and Atherogenesis. Cytokines affecting endothelial and smooth muscle cells in vascular disease J. Lipid Res., June 1, 2005; 46(6): 1081 - 1092. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Lehoux and A. Tedgui Making Up and Breaking Up: The Tortuous Ways of the Vascular Wall Arterioscler Thromb Vasc Biol, May 1, 2005; 25(5): 892 - 894. [Full Text] [PDF]
|
|
|
|
|
|
K. Sudhir Lipoprotein-Associated Phospholipase A2, a Novel Inflammatory Biomarker and Independent Risk Predictor for Cardiovascular Disease J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 3100 - 3105. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Oral presentations Lupus, March 1, 2005; 14(3): 215 - 262. [PDF]
|
|
|
|
|
|
P. Tobias and L. K. Curtiss Thematic review series: The Immune System and Atherogenesis. Paying the price for pathogen protection: toll receptors in atherogenesis J. Lipid Res., March 1, 2005; 46(3): 404 - 411. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||